Histamine Intolerance vs MCAS: How to Tell The Difference
Quick answer: Histamine intolerance (HIT) is a food-triggered build-up problem caused by low activity of the enzyme DAO, which normally breaks down histamine from meals. Mast cell activation syndrome (MCAS) is an immune-cell disorder where mast cells release histamine and other chemicals too easily, triggered by far more than food. Both cause flushing, hives, gut symptoms, and headaches, which is exactly why they get mixed up.
You cut out curd, kanji, leftovers, tomatoes, and aged cheese. You felt a bit better. Then, weeks later, the flushing, the racing heart, and the random hives came back anyway — after foods that were never on your "avoid" list.
If this sounds familiar, you're likely facing the histamine intolerance vs MCAS question— two very different conditions that share one loud symptom: too much histamine acting up in your body. Getting the label wrong is the single biggest reason people stay stuck for years.
What Is Histamine Intolerance (HIT)?
Histamine intolerance isn't an allergy. It's a build-up problem. Your gut lining makes an enzyme called diamine oxidase (DAO), whose job is to break down histamine from food before it overwhelms your system. When DAO activity is too low, histamine from your last meal piles up faster than your body can clear it (Maintz & Novak, 2007).
This can happen for two reasons:
1. Genetic. Several common variants of the AOC1 gene (the gene that codes for DAO) reduce enzyme activity. Studies have found these variants in the majority of people with HIT symptoms — one pilot study found 79% of symptomatic patients carried at least one of four known DAO-lowering variants (Okutan et al., 2024), and a separate newborn screening study found these same variants in roughly two-thirds of the general population, suggesting genetic susceptibility is far more common than actual symptomatic HIT — meaning genetics alone rarely tells the whole story (Manzotti et al., 2025).
2. Acquired. Gut inflammation, certain medications, and alcohol can all suppress DAO activity even in people with normal genes. This is why a flare-up of gut inflammation (from IBS, gluten reactions, or a stomach bug) can suddenly make someone histamine-sensitive who never was before.
There's a third twist that explains a lot of confusion: DAO doesn't just process histamine. Other "biogenic amines" — putrescine and cadaverine, found in leftovers, cured meats, and over-ripe or spoiling food — actively compete with histamine for the same enzyme and can slow histamine breakdown by 70–80% (Comas-Basté et al., 2022).
This is likely why some people react far more to day-old dal or leftover fish curry than to a freshly cooked version of the exact same dish, and why "histamine content" charts alone don't fully predict who reacts to what.
Foods That Commonly Trigger HIT
Category | Examples |
Fermented foods | Curd left out too long, kanji, sauerkraut, kimchi, aged cheese, wine, beer |
Cured & leftover proteins | Cured meats, smoked fish, leftovers reheated more than once |
High-histamine vegetables | Tomatoes, spinach, brinjal (eggplant), fermented soy |
Histamine-releasing foods | Citrus, strawberries, chocolate, shellfish (these don't contain much histamine themselves but trigger your own cells to release it) |
Other interfering amines | Aged, cured, or spoiling foods (putrescine/cadaverine content rises with age, not just histamine) |
Typical HIT pattern: symptoms appear 20 minutes to a few hours after eating, and they scale with how much you ate — more histamine-rich food generally means a stronger reaction.
What Is Mast Cell Activation Syndrome (MCAS)?
MCAS is a different animal entirely. Mast cells are immune cells stationed throughout your gut, skin, and airways. When triggered, they release a cocktail of chemicals — histamine, but also tryptase, prostaglandins, and leukotrienes.
In MCAS, these cells fire too often, too easily, or too strongly, and food is just one of many possible triggers alongside heat, exercise, stress, fragrances, hormonal shifts, and infections (Weiler et al., 2024).
MCAS has real diagnostic criteria, agreed on by international consensus:
Typical, recurrent, severe symptoms across two or more organ systems at the same time
A measurable rise in serum tryptase during or shortly after an episode — specifically, at least 120% of the person's own baseline plus 2 ng/mL, checked within four hours of a flare
Symptoms that improve with mast-cell-targeted treatment (antihistamines, mast cell stabilizers)
Elevated tryptase alone doesn't prove MCAS, and normal tryptase doesn't rule it out — the pattern, tested properly, is what matters (Valent et al., 2019; Butterfield & Weiler, 2024).
A Wrinkle Almost Nobody Explains: Hereditary Alpha-Tryptasemia (HαT)
About 4–6% of people carry extra copies of the TPSAB1 gene, which raises their baseline tryptase permanently, a genetic trait called hereditary alpha-tryptasemia, not a disease in itself (Lyons et al., 2021).
In one large study of patients referred for mast-cell-type symptoms, 80% were women, and most had multi-system symptoms including gut, skin, and cardiovascular complaints, with partial relief on antihistamines (Lyons et al., 2021). HαT can exist on its own, alongside MCAS, or alongside mastocytosis — which is exactly why a single tryptase number, without genetic context, often confuses rather than clarifies a diagnosis.
Histamine Intolerance Vs MCAS
Histamine Intolerance | MCAS | |
Root issue | Reduced histamine breakdown (low DAO activity) | Mast cells releasing mediators too easily or too often |
Main trigger | Histamine-rich or histamine-releasing foods | Food, heat, stress, exercise, hormones, infection, fragrance |
Mediators involved | Mainly histamine | Histamine plus tryptase, prostaglandins, leukotrienes |
Pattern | Dose-dependent, tied to specific meals | Episodic, multi-system, less predictable |
Diagnosis | Clinical history + elimination/reintroduction; serum DAO has real limits (Arih et al., 2023) | Consensus criteria: event-related tryptase rise + 2+ organ systems + treatment response |
Who leads treatment | Nutritionist-led diet management | Allergist/immunologist; nutrition supports it |
Where Symptoms Overlap (And Why That's the Trap)
System | Seen in HIT | Seen in MCAS |
Gut | Bloating, diarrhoea, cramping, reflux | Same, plus nausea and unpredictable flares |
Skin | Flushing, hives, itching | Same, often more sudden and severe |
Heart/circulation | Mild palpitations after meals | Racing heart, dizziness, blood pressure drops |
Head | Headaches, migraines | Headaches, brain fog, anxiety-like symptoms during flares |
Timing | Predictable, food-linked | Can occur with no obvious trigger |
This overlap isn't a coincidence. Mast cells are themselves a source of histamine, and research has shown that specific gut bacteria, most notably Klebsiella aerogenes, can produce enough histamine on their own to activate mast cells and cause abdominal pain, entirely independent of what you ate that day (De Palma et al., 2022; Wang et al., 2022).
A related study found that IBS patients with high urinary histamine had visibly higher gut mast cell counts, and reducing fermentable carbohydrates lowered both (De Palma et al., 2022). This is part of why low-FODMAP and low-histamine diets so often overlap, and exactly why MCAS gets missed. A low-histamine diet frequently helps both conditions partially.
People improve a little, credit food entirely, and never get the medical workup that would have caught mast cells as the deeper driver.
Where Nutrition Actually Helps
For HIT: structured, temporary low-histamine eating, combined with identifying acquired DAO suppressors (poor gut health, alcohol, certain medications), genuinely works. A large randomized, placebo-controlled trial is currently underway testing exactly this combination — low-histamine diet with and without DAO enzyme supplementation — across 400 patients (Duelo et al., 2024). Earlier retrospective data already shows people with confirmed low DAO respond well to a combined diet-plus-supplement approach over several months (Manzotti et al., 2016; Schnedl et al., 2019).
For MCAS: nutrition is a support, not a treatment. Diet can lower your total mediator load, and certain nutrients have real lab evidence behind them — quercetin, in particular, has been shown to inhibit mast cell release of histamine and tryptase more effectively than the pharmaceutical mast cell stabilizer cromolyn in human cell studies (Weng et al., 2012). But MCAS needs a proper diagnosis and a doctor first; diet alone rarely resolves it because most triggers aren't food.
Frequently Missed Questions, Answered
Why do I react to leftovers but not the same dish fresh? Because histamine (and competing amines like putrescine) rise the longer food sits, even refrigerated. It's not really about the ingredient — it's about time.
Can gut health actually fix this? For HIT, often significantly, because gut inflammation is one of the biggest acquired causes of low DAO. For MCAS, gut health can reduce your symptom load, but it won't override an immune-cell disorder on its own.
Is a DAO blood test worth doing? It can help, but it's not perfect — studies show DAO levels vary by time of day and don't perfectly separate people with HIT from those without (Arih et al., 2023). It's one data point, not a yes/no verdict.
Could I have histamine intolerance and MCAS at once? Yes. They're not mutually exclusive, and the overlap in mediators (both involve mast cells and histamine) means many people genuinely have elements of both — which is exactly why the histamine intolerance vs MCAS distinction isn't always either/or.
Quick Self-Check
Symptoms only after specific high-histamine meals, and they scale with portion size → more HIT-like
Symptoms after heat, workouts, stress, perfume, or seemingly out of nowhere, involving skin, gut, and heart rate together → worth ruling out MCAS
Also have joint hypermobility or a racing heart on standing up? MCAS clusters with hypermobile Ehlers-Danlos syndrome and POTS far more than chance would predict — one study found MCAS in 31% of patients with both POTS and EDS, versus 2% without (Wang et al., 2021; Farley et al., 2025).
The Bottom Line
Both conditions are real. Neither is "in your head." But treating MCAS like a food problem, or treating HIT like it needs an allergist and lifelong medication, wastes time you don't have to waste. The right next step depends on which pattern actually fits you, and that's worth figuring out properly rather than guessing your way through another elimination diet.
If your symptoms don't fully resolve on a low-histamine diet, that itself is diagnostic information, not a sign you're doing it wrong. That's exactly where a structured gut-health assessment earns its keep.
👉 Work with Meenu Balaji, gut health nutritionist, to map your actual triggers instead of guessing. Book a consultation.
References
Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007. https://pubmed.ncbi.nlm.nih.gov/17490952/
Arih K, et al. Evaluation of Serum Diamine Oxidase as a Diagnostic Test for Histamine Intolerance. Nutrients. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10574399/
Histamine Intolerance: Symptoms, Diagnosis, and Beyond. https://pmc.ncbi.nlm.nih.gov/articles/PMC11054089/
The Use of DAO as a Marker for Histamine Intolerance in a Population-Based Survey. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346277/
Schnedl WJ, et al. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859183/
Kofler H, et al. Histamine 50-Skin-Prick Test: A Tool to Diagnose Histamine Intolerance. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3658496/
Duelo A, et al. Study Protocol for a Randomized, Placebo-Controlled Trial on Low-Histamine Diet and DAO Supplementation. Nutrients. 2024. https://pubmed.ncbi.nlm.nih.gov/39796463/
Comas-Basté O, et al. The Rate of Histamine Degradation by Diamine Oxidase Is Compromised by Other Biogenic Amines. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175030/
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003468/
Toward Oral Supplementation of Diamine Oxidase for the Treatment of Histamine Intolerance. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268349/
Investigating the Role of Bacterial Histamine Metabolism in Visceral Hyperalgesia. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10871931/
Wang Y, et al. Gut bacteria interact directly with colonic mast cells in a humanized mouse model of IBS. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341375/
Lactobacillus plantarum and GOS Synbiotic Relieve IBS by Attenuating Mast Cell Hyperactivation. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12113827/
Weng Z, et al. Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314669/
Using the Right Criteria for MCAS. https://pmc.ncbi.nlm.nih.gov/articles/PMC10866766/
Diagnosis and management of mast cell activation syndrome (MCAS) in Canada: a practical approach. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12639879/
Weinstock LB, et al. The Relationship Between hEDS, POTS, and MCAS. https://pubmed.ncbi.nlm.nih.gov/31267471/
Farley M, et al. Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among POTS and EDS patients: A systematic review. https://pubmed.ncbi.nlm.nih.gov/40185471/
Pilot Study on the Prevalence of Diamine Oxidase Gene Variants in Patients with Symptoms of Histamine Intolerance. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054051/
The Prevalence of AOC1 Gene SNPs Associated with DAO Deficiency in Healthy Newborns. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11855045/
Lyons JJ, et al. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis. https://pubmed.ncbi.nlm.nih.gov/33465452/
Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957558/
Comments